935 related articles for article (PubMed ID: 28132924)
21. Sodium Lactate Accelerates M2 Macrophage Polarization and Improves Cardiac Function after Myocardial Infarction in Mice.
Zhang J; Huang F; Chen L; Li G; Lei W; Zhao J; Liao Y; Li Y; Li C; Chen M
Cardiovasc Ther; 2021; 2021():5530541. PubMed ID: 34194542
[TBL] [Abstract][Full Text] [Related]
22. Characterization of the transport activity of SGLT2/MAP17, the renal low-affinity Na
Coady MJ; Wallendorff B; Lapointe JY
Am J Physiol Renal Physiol; 2017 Aug; 313(2):F467-F474. PubMed ID: 28592437
[TBL] [Abstract][Full Text] [Related]
23. Dapagliflozin prevents ERK activation and SGLT2-dependent endoglin upregulation in a mechanically provoked cardiac injury model.
Yeh TC; Wu YC; Wong TY; Sun GC; Tseng CJ; Cheng PW
Physiol Rep; 2024 Apr; 12(7):e15990. PubMed ID: 38575554
[TBL] [Abstract][Full Text] [Related]
24. Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes.
Shin SJ; Chung S; Kim SJ; Lee EM; Yoo YH; Kim JW; Ahn YB; Kim ES; Moon SD; Kim MJ; Ko SH
PLoS One; 2016; 11(11):e0165703. PubMed ID: 27802313
[TBL] [Abstract][Full Text] [Related]
25. Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2.
Wu Q; Yao Q; Hu T; Yu J; Jiang K; Wan Y; Tang Q
Cell Rep Med; 2023 Dec; 4(12):101334. PubMed ID: 38118414
[TBL] [Abstract][Full Text] [Related]
26. IL33 attenuates ventricular remodeling after myocardial infarction through inducing alternatively activated macrophages ethical standards statement.
Li J; Shen D; Tang J; Wang Y; Wang B; Xiao Y; Cao C; Shi X; Liu HM; Zhao W; Zhang J
Eur J Pharmacol; 2019 Jul; 854():307-319. PubMed ID: 31039343
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic activation of signal transducer and activator of transcription 3 by interleukin-11 ameliorates cardiac fibrosis after myocardial infarction.
Obana M; Maeda M; Takeda K; Hayama A; Mohri T; Yamashita T; Nakaoka Y; Komuro I; Takeda K; Matsumiya G; Azuma J; Fujio Y
Circulation; 2010 Feb; 121(5):684-91. PubMed ID: 20100971
[TBL] [Abstract][Full Text] [Related]
28. Cardioprotection of dapagliflozin and vildagliptin in rats with cardiac ischemia-reperfusion injury.
Tanajak P; Sa-Nguanmoo P; Sivasinprasasn S; Thummasorn S; Siri-Angkul N; Chattipakorn SC; Chattipakorn N
J Endocrinol; 2018 Feb; 236(2):69-84. PubMed ID: 29142025
[TBL] [Abstract][Full Text] [Related]
29. Amelioration of diastolic dysfunction by dapagliflozin in a non-diabetic model involves coronary endothelium.
Cappetta D; De Angelis A; Ciuffreda LP; Coppini R; Cozzolino A; Miccichè A; Dell'Aversana C; D'Amario D; Cianflone E; Scavone C; Santini L; Palandri C; Naviglio S; Crea F; Rota M; Altucci L; Rossi F; Capuano A; Urbanek K; Berrino L
Pharmacol Res; 2020 Jul; 157():104781. PubMed ID: 32360273
[TBL] [Abstract][Full Text] [Related]
30. Dapagliflozin, SGLT2 Inhibitor, Attenuates Renal Ischemia-Reperfusion Injury.
Chang YK; Choi H; Jeong JY; Na KR; Lee KW; Lim BJ; Choi DE
PLoS One; 2016; 11(7):e0158810. PubMed ID: 27391020
[TBL] [Abstract][Full Text] [Related]
31. Dapagliflozin: a new sodium-glucose cotransporter 2 inhibitor for treatment of type 2 diabetes.
Vivian EM
Am J Health Syst Pharm; 2015 Mar; 72(5):361-72. PubMed ID: 25694411
[TBL] [Abstract][Full Text] [Related]
32. The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Renal and Liver Disease in Western Diet Induced Obesity Mice.
Wang D; Luo Y; Wang X; Orlicky DJ; Myakala K; Yang P; Levi M
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29301371
[TBL] [Abstract][Full Text] [Related]
33. SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart.
Li C; Zhang J; Xue M; Li X; Han F; Liu X; Xu L; Lu Y; Cheng Y; Li T; Yu X; Sun B; Chen L
Cardiovasc Diabetol; 2019 Feb; 18(1):15. PubMed ID: 30710997
[TBL] [Abstract][Full Text] [Related]
34. SGLT2 inhibitor dapagliflozin attenuates cardiac fibrosis and inflammation by reverting the HIF-2α signaling pathway in arrhythmogenic cardiomyopathy.
Yang Z; Li T; Xian J; Chen J; Huang Y; Zhang Q; Lin X; Lu H; Lin Y
FASEB J; 2022 Jul; 36(7):e22410. PubMed ID: 35713937
[TBL] [Abstract][Full Text] [Related]
35. Dapagliflozin Alleviates Coxsackievirus B3-induced Acute Viral Myocarditis by Regulating the Macrophage Polarization Through Stat3-related Pathways.
Yan P; Song X; Tran J; Zhou R; Cao X; Zhao G; Yuan H
Inflammation; 2022 Oct; 45(5):2078-2090. PubMed ID: 35676606
[TBL] [Abstract][Full Text] [Related]
36. Dapagliflozin, an oral sodium glucose cotransporter type 2 inhibitor for the treatment of type 2 diabetes mellitus.
Calado J
IDrugs; 2009 Dec; 12(12):785-98. PubMed ID: 19943222
[TBL] [Abstract][Full Text] [Related]
37. Combined SGLT2 and DPP4 Inhibition Reduces the Activation of the Nlrp3/ASC Inflammasome and Attenuates the Development of Diabetic Nephropathy in Mice with Type 2 Diabetes.
Birnbaum Y; Bajaj M; Yang HC; Ye Y
Cardiovasc Drugs Ther; 2018 Apr; 32(2):135-145. PubMed ID: 29508169
[TBL] [Abstract][Full Text] [Related]
38. HIMF deletion ameliorates acute myocardial ischemic injury by promoting macrophage transformation to reparative subtype.
Li Y; Dong M; Wang Q; Kumar S; Zhang R; Cheng W; Xiang J; Wang G; Ouyang K; Zhou R; Xie Y; Lu Y; Yi J; Duan H; Liu J
Basic Res Cardiol; 2021 Apr; 116(1):30. PubMed ID: 33893593
[TBL] [Abstract][Full Text] [Related]
39. SGLT2 Inhibition by Intraperitoneal Dapagliflozin Mitigates Peritoneal Fibrosis and Ultrafiltration Failure in a Mouse Model of Chronic Peritoneal Exposure to High-Glucose Dialysate.
Balzer MS; Rong S; Nordlohne J; Zemtsovski JD; Schmidt S; Stapel B; Bartosova M; von Vietinghoff S; Haller H; Schmitt CP; Shushakova N
Biomolecules; 2020 Nov; 10(11):. PubMed ID: 33228017
[TBL] [Abstract][Full Text] [Related]
40. Dapagliflozin improves left ventricular remodeling and aorta sympathetic tone in a pig model of heart failure with preserved ejection fraction.
Zhang N; Feng B; Ma X; Sun K; Xu G; Zhou Y
Cardiovasc Diabetol; 2019 Aug; 18(1):107. PubMed ID: 31429767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
